Lange L - Search Results

1

Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide.

Hamm B, Staks T, Taupitz M, Maibauer R, Speidel A, Huppertz A, Frenzel T, Lawaczeck R, Wolf KJ, Lange L. Hamm B, et al. Among authors: lange l. J Magn Reson Imaging. 1994 Sep-Oct;4(5):659-68. doi: 10.1002/jmri.1880040508. J Magn Reson Imaging. 1994. PMID: 7981510 Clinical Trial.

2

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

Hamm B, Staks T, Mühler A, Bollow M, Taupitz M, Frenzel T, Wolf KJ, Weinmann HJ, Lange L. Hamm B, et al. Among authors: lange l. Radiology. 1995 Jun;195(3):785-92. doi: 10.1148/radiology.195.3.7754011. Radiology. 1995. PMID: 7754011 Clinical Trial.

3

Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers.

Staks T, Schuhmann-Giampieri G, Frenzel T, Weinmann HJ, Lange L, Platzek J. Staks T, et al. Among authors: lange l. Invest Radiol. 1994 Jul;29(7):709-15. doi: 10.1097/00004424-199407000-00008. Invest Radiol. 1994. PMID: 7960618 Clinical Trial.

4

[Human testing of the nuclear spin tomographic contrast medium gadolinium-DTPA. Tolerance, contrast affect and the 1st clinical results].

Schörner W, Felix R, Laniado M, Lange L, Weinmann HJ, Claussen C, Fiegler W, Speck U, Kazner E. Schörner W, et al. Among authors: lange l. Rofo. 1984 May;140(5):493-500. doi: 10.1055/s-2008-1053017. Rofo. 1984. PMID: 6429753 Clinical Trial. German.

5

Dose-response relationship of topically applied methylprednisolone aceponate (MPA) in healthy volunteers.

Kecskés A, Jahn P, Wendt H, Lange L, Kuhlmann RK. Kecskés A, et al. Among authors: lange l. Eur J Clin Pharmacol. 1992;43(2):157-9. doi: 10.1007/BF01740663. Eur J Clin Pharmacol. 1992. PMID: 1425873 Clinical Trial.

6

Local tolerability of topically applied methylprednisolone aceponate.

Kecskés A, Jahn P, Lange L. Kecskés A, et al. Among authors: lange l. J Am Acad Dermatol. 1993 May;28(5 Pt 1):786-8. doi: 10.1016/s0190-9622(09)80275-2. J Am Acad Dermatol. 1993. PMID: 8496430 Clinical Trial. No abstract available.

7

Systemic effects of topically applied methylprednisolone aceponate in healthy volunteers.

Kecskés A, Jahn P, Matthes H, Kuhlmann RK, Lange L. Kecskés A, et al. Among authors: lange l. J Am Acad Dermatol. 1993 May;28(5 Pt 1):789-92. doi: 10.1016/s0190-9622(09)80276-4. J Am Acad Dermatol. 1993. PMID: 8496431 Clinical Trial. No abstract available.

8

Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity.

Kecskés A, Heger-Mahn D, Kuhlmann RK, Lange L. Kecskés A, et al. Among authors: lange l. J Am Acad Dermatol. 1993 Oct;29(4):576-80. doi: 10.1016/0190-9622(93)70224-h. J Am Acad Dermatol. 1993. PMID: 8408793 Clinical Trial.

9

Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.

Kecskés A, Jahn P, Wendt H, Kleine-Kuhlmann R, Lange L. Kecskés A, et al. Among authors: lange l. Arzneimittelforschung. 1993 Feb;43(2):144-7. Arzneimittelforschung. 1993. PMID: 8457237 Clinical Trial.

10

Validation of an in vivo wound healing model for the quantification of pharmacological effects on epidermal regeneration.

Lévy JJ, von Rosen J, Gassmüller J, Kleine Kuhlmann R, Lange L. Lévy JJ, et al. Among authors: lange l. Dermatology. 1995;190(2):136-41. doi: 10.1159/000246663. Dermatology. 1995. PMID: 7727835 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

939 results

Search Page

Filters